ACTIONABLE ADVICE FOR FINANCIAL ADVISORS: Newsletters and Commentaries Focused on Investment Strategy

Follow us on

    Last 14 days

Most Popular Articles


Most Popular Commentaries

    Last 12 Months

Most Popular Articles


Most Popular Commentaries



More by the Same Author

Equities
   Value
Global Markets
   Europe
   Global
Investment Strategies
   General
Investments
   Investments

Macroeconomic Risk? That's So 2012

February 12th, 2013

by Tom West

of Columbia Management

Fourth quarter earnings are modestly beating expectations, albeit by less than the amount expectations were lowered during the quarter. And while every sector and industry is different, the market seemed to give companies (even with their cautious outlook for 2013) the benefit of the doubt they can manage through a tough demand environment. This may be based on a general belief that the risk of extreme events is dropping. Some “color” from some of the major sectors:

Tech companies selling into corporations saw a little lift in results in the fourth quarter, which many are attributing to a broad “budget flush” on the heels of very cautious spending in the first three quarters of the year. The bullish case for tech investment is that enterprise customers will perceive lower risk of global financial shocks, and expand their list of allowable technology investment from near term must do, to projects and system upgrades that have a good return on investment, but a longer payback period. On the consumer side of tech, things remain tough across the spectrum of goods — PCs, flat screen TVs, smart-phones, etc.

In financials, the interest rate backdrop continued to pressure net interest spreads for the traditional banking business, while the investment banking business enjoyed healthy underwriting and trading volumes, as compared to last year's fourth quarter. Now that credit losses have largely normalized, management focus remains on cutting costs (firing workers) to offset rate pressure, regulatory burdens and litigation expenses. Investors see macroeconomic risks as diffused and are seeing signs that activity levels and volumes may be normalizing capital markets companies.

Healthcare stocks also seem to be getting a glass-is-half-full view. Despite patent expirations at the major pharmaceutical companies, generally lackluster utilization trend in the healthcare system and an incomplete picture of how firms will manage through new legislation, the stocks seem to be taking the view that the companies will be able to work through this tough environment.

In the industrial sector, there is a general sense that, while Europe is still an issue, the U.S. continues to recover and stimulus is starting to take hold in China. Many companies did note an inflection in orders towards the end of the fourth quarter but it remains to be seen whether this was due to an actual pickup in confidence or just normal year end spending and companies taking advantage of bonus depreciation which was set to expire. Guidance attempted to lower expectations for the first and second quarter with a ramp in the second half of the year. This will prove overly optimistic without an acceleration of near-term order trends.

So, is the market rationally valuing and netting out these data points to come up with higher stock prices? Or is it a matter of finding bright spots to justify higher stock prices that have been pulled higher by low rates and higher asset prices in general? I suspect it is a little bit of both.

Disclosure

The views expressed are as of 2/11/13, may change as market or other conditions change, and may differ from views expressed by other Columbia Management Investment Advisers, LLC (CMIA) associates or affiliates. Actual investments or investment decisions made by CMIA and its affiliates, whether for its own account or on behalf of clients, will not necessarily reflect the views expressed. This information is not intended to provide investment advice and does not account for individual investor circumstances. Investment decisions should always be made based on an investor's specific financial needs, objectives, goals, time horizon, and risk tolerance. Asset classes described may not be suitable for all investors. Past performance does not guarantee future results and no forecast should be considered a guarantee either. Since economic and market conditions change frequently, there can be no assurance that the trends described here will continue or that the forecasts are accurate.

This material may contain certain statements that may be deemed forward-looking. Please note that any such statements are not guarantees of any future performance and actual results or developments may differ materially from those discussed. There is no guarantee that investment objectives will be achieved or that any particular investment will be profitable.

Investment products are not federally or FDIC-insured, are not deposits or obligations of, or guaranteed by any financial institution, and involve investment risks including possible loss of principal and fluctuation in value.

Securities products offered through Columbia Management Investment Distributors, Inc., member FINRA. Advisory services provided by Columbia Management Investment Advisers, LLC.

© 2013 Columbia Management Investment Advisers, LLC. All rights reserved. 152207

www.columbiamanagement.com

Website by the Boston Web Company